HCA Holdings, Inc. (NYSE:HCA) – Analysts at Oppenheimer Holdings reduced their Q1 2018 earnings per share estimates for HCA Holdings in a report released on Tuesday, according to Zacks Investment Research. Oppenheimer Holdings analyst M. Wiederhorn now expects that the company will earn $1.70 per share for the quarter, down from their prior forecast of $1.72. Oppenheimer Holdings has a “Buy” rating and a $90.00 price target on the stock. Oppenheimer Holdings also issued estimates for HCA Holdings’ Q2 2018 earnings at $1.76 EPS, Q3 2018 earnings at $1.63 EPS, Q4 2018 earnings at $1.99 EPS and FY2018 earnings at $7.08 EPS.
HCA Holdings (NYSE:HCA) last released its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.21. HCA Holdings had a net margin of 6.13% and a negative return on equity of 47.16%. The firm had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. During the same quarter last year, the business earned $1.45 EPS. The business’s revenue was up 4.1% on a year-over-year basis.
ILLEGAL ACTIVITY WARNING: “Brokers Set Expectations for HCA Holdings, Inc.’s Q1 2018 Earnings (HCA)” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/12/oppenheimer-holdings-brokers-cut-earnings-estimates-for-hca-holdings-inc-hca.html.
Several other equities research analysts have also commented on HCA. Robert W. Baird reissued a “buy” rating on shares of HCA Holdings in a report on Thursday, September 28th. Credit Suisse Group initiated coverage on shares of HCA Holdings in a research note on Thursday, November 2nd. They set an “outperform” rating and a $95.00 target price on the stock. Piper Jaffray Companies restated a “buy” rating and issued a $92.00 price target on shares of HCA Holdings in a research report on Wednesday, October 4th. Cantor Fitzgerald restated a “buy” rating and issued a $95.00 price target on shares of HCA Holdings in a research report on Friday, October 13th. Finally, Raymond James Financial, Inc. cut HCA Holdings from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have issued a buy rating to the company’s stock. HCA Holdings currently has an average rating of “Buy” and an average target price of $89.95.
Shares of HCA Holdings (NYSE:HCA) traded down $0.73 during midday trading on Thursday, reaching $78.68. 1,804,600 shares of the company’s stock traded hands, compared to its average volume of 3,287,103. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. The firm has a market cap of $27,856.89, a PE ratio of 11.94, a price-to-earnings-growth ratio of 1.16 and a beta of 0.50. HCA Holdings has a twelve month low of $68.02 and a twelve month high of $91.03.
HCA Holdings announced that its board has approved a stock repurchase program on Tuesday, October 31st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to buy shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.
In other news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $79.87, for a total transaction of $171,720.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders sold 6,450 shares of company stock valued at $511,163 over the last 90 days. 2.90% of the stock is currently owned by company insiders.
A number of large investors have recently made changes to their positions in HCA. Northwestern Mutual Wealth Management Co. boosted its holdings in HCA Holdings by 14.0% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after purchasing an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. increased its position in shares of HCA Holdings by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after acquiring an additional 320 shares during the period. Atlantic Trust LLC purchased a new position in shares of HCA Holdings in the second quarter valued at about $118,000. Lee Financial Co purchased a new position in shares of HCA Holdings in the second quarter valued at about $125,000. Finally, Acrospire Investment Management LLC increased its position in shares of HCA Holdings by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after acquiring an additional 200 shares during the period. 75.18% of the stock is owned by hedge funds and other institutional investors.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Get a free copy of the Zacks research report on HCA Holdings (HCA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.